ReviewCurrent treatment options in oncology2024

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer.

Hervé Bischoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.